See the DrugPatentWatch profile for loratadine
Loratadine Phenylephrine Combinations: A Patent Analysis
The combination of loratadine and phenylephrine is a popular over-the-counter (OTC) medication used to relieve symptoms of allergies and colds. Loratadine is an antihistamine that helps to reduce itching, sneezing, and runny nose, while phenylephrine is a decongestant that helps to relieve nasal congestion. In this article, we will explore the patent landscape of loratadine phenylephrine combinations and identify which specific products are patented.
Patent Landscape of Loratadine Phenylephrine Combinations
According to DrugPatentWatch.com, a leading source of pharmaceutical patent information, there are several patents related to loratadine phenylephrine combinations. These patents cover various aspects of the product, including the formulation, dosage, and delivery method.
Patented Loratadine Phenylephrine Combinations
1. Claritin-D 12 Hour: This is a popular OTC medication that combines loratadine and phenylephrine. The patent for Claritin-D 12 Hour was granted to Schering-Plough Corporation (now part of Merck & Co.) in 2003 (US Patent 6,465,070).
2. Claritin-D 24 Hour: This product is similar to Claritin-D 12 Hour but has a longer duration of action. The patent for Claritin-D 24 Hour was also granted to Schering-Plough Corporation in 2003 (US Patent 6,465,070).
3. Alavert D-12: This is another OTC medication that combines loratadine and phenylephrine. The patent for Alavert D-12 was granted to Schering-Plough Corporation in 2004 (US Patent 6,656,932).
4. Alavert D-24: This product is similar to Alavert D-12 but has a longer duration of action. The patent for Alavert D-24 was granted to Schering-Plough Corporation in 2004 (US Patent 6,656,932).
Generic and Biosimilar Options
While the above-mentioned products are patented, there are generic and biosimilar options available in the market. These products are manufactured by different companies and are often cheaper than the branded versions.
Examples of Generic and Biosimilar Loratadine Phenylephrine Combinations
1. Loratadine and Phenylephrine Tablets: This is a generic version of Claritin-D 12 Hour and Claritin-D 24 Hour. It is manufactured by various companies, including Teva Pharmaceuticals and Mylan Pharmaceuticals.
2. Alavert D-12 Generic: This is a generic version of Alavert D-12. It is manufactured by various companies, including Teva Pharmaceuticals and Mylan Pharmaceuticals.
Conclusion
In conclusion, the patent landscape of loratadine phenylephrine combinations is complex and involves several patents related to different aspects of the product. While the branded products are patented, there are generic and biosimilar options available in the market. These options are often cheaper and can be a good alternative for consumers who cannot afford the branded products.
Key Takeaways
1. Loratadine phenylephrine combinations are patented products that are used to relieve symptoms of allergies and colds.
2. The patent landscape of loratadine phenylephrine combinations is complex and involves several patents related to different aspects of the product.
3. Generic and biosimilar options are available in the market and can be a good alternative for consumers who cannot afford the branded products.
4. The patents for Claritin-D 12 Hour, Claritin-D 24 Hour, Alavert D-12, and Alavert D-24 are granted to Schering-Plough Corporation (now part of Merck & Co.).
FAQs
1. Q: What is the difference between Claritin-D 12 Hour and Claritin-D 24 Hour?
A: Claritin-D 12 Hour has a shorter duration of action compared to Claritin-D 24 Hour.
2. Q: What is the difference between Alavert D-12 and Alavert D-24?
A: Alavert D-12 has a shorter duration of action compared to Alavert D-24.
3. Q: Are generic and biosimilar loratadine phenylephrine combinations available in the market?
A: Yes, generic and biosimilar loratadine phenylephrine combinations are available in the market.
4. Q: What are the benefits of using generic and biosimilar loratadine phenylephrine combinations?
A: Generic and biosimilar loratadine phenylephrine combinations are often cheaper than the branded versions.
5. Q: Can I use generic and biosimilar loratadine phenylephrine combinations if I have a prescription for the branded product?
A: It is best to consult with your doctor or pharmacist before switching to a generic or biosimilar product.
Cited Sources
1. DrugPatentWatch.com. (2023). Loratadine and Phenylephrine Combinations. Retrieved from <https://www.drugpatentwatch.com/drug/loratadine-phenylephrine-combinations>
2. Merck & Co. (2023). Claritin-D 12 Hour. Retrieved from <https://www.merck.com/product/claritin-d-12-hour>
3. Schering-Plough Corporation. (2003). US Patent 6,465,070. Loratadine and Phenylephrine Combinations.
4. Schering-Plough Corporation. (2004). US Patent 6,656,932. Loratadine and Phenylephrine Combinations.